An emerging strategy in cancer treatment involves combining mTOR inhibitors with hormonal therapy to stop the growth of hormone-sensitive cancers.525 These immunomodulatory effects provide a rationale for the synergistic efficacy when paired with immune checkpoint inhibitors. Here, MTOR is linked to cancer.